Objective The University of Washington Quality of Life (UW-QOL) questionnaire is one of the most widely used instruments to evaluate the quality of life of head and neck cancer patients. The aim of this study was to perform a Spanish translation and validation of the UW-QOL questionnaire. Study Design A cross-sectional study. Setting Three tertiary-care hospitals and a laryngectomee rehabilitation center. Subjects and Methods The translation and cultural adaptation of the questionnaire were performed following accepted international guidelines. The psychometric validation was performed on a consecutive series of patients treated for squamous cell carcinoma of the upper aerodigestive tract with no signs of relapse, recruited from May 2007 to...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
Quality of Life (QOL) is now a standard end-point in clinical trials. The aim of this non-cohort stu...
Despite modern advances in the treatment of head and neck cancer, the survival rate fails to improve...
of Life (UW-QOL) questionnaire is an English-language survey instrument used worldwide to assess the...
PURPOSE: The aim of this study was to define the scales and test the validity, reliability, and sens...
The purposes of this three-phase study were to: (1) translate and evaluate the burden, content, and ...
Aims: To present the first cross-culture validation of the European organization for research and tr...
BACKGROUND: The goal of treating cancer patients is to cure the patients and improve their quality o...
Background The objective of this study was to pilot test an updated version of the European Organiza...
Aims: To present the first cross-culture validation of the European organization for research and t...
SummaryObjectiveQuality of life (QoL) is now as much an assessment criterion in clinical trials in h...
Fundamento: El Grupo de Calidad de Vida (C.V.) de la EORTC ha desarrollado un cuestionario de evalua...
Aims: To present the first cross-culture validation of the European organization for research and t...
Fundamento: El Grupo de Calidad de Vida (C.V.) de la EORTC ha desarrollado un cuestionario de evalua...
Background The objective of this study was to pilot test an updated version of the European Organiza...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
Quality of Life (QOL) is now a standard end-point in clinical trials. The aim of this non-cohort stu...
Despite modern advances in the treatment of head and neck cancer, the survival rate fails to improve...
of Life (UW-QOL) questionnaire is an English-language survey instrument used worldwide to assess the...
PURPOSE: The aim of this study was to define the scales and test the validity, reliability, and sens...
The purposes of this three-phase study were to: (1) translate and evaluate the burden, content, and ...
Aims: To present the first cross-culture validation of the European organization for research and tr...
BACKGROUND: The goal of treating cancer patients is to cure the patients and improve their quality o...
Background The objective of this study was to pilot test an updated version of the European Organiza...
Aims: To present the first cross-culture validation of the European organization for research and t...
SummaryObjectiveQuality of life (QoL) is now as much an assessment criterion in clinical trials in h...
Fundamento: El Grupo de Calidad de Vida (C.V.) de la EORTC ha desarrollado un cuestionario de evalua...
Aims: To present the first cross-culture validation of the European organization for research and t...
Fundamento: El Grupo de Calidad de Vida (C.V.) de la EORTC ha desarrollado un cuestionario de evalua...
Background The objective of this study was to pilot test an updated version of the European Organiza...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
Quality of Life (QOL) is now a standard end-point in clinical trials. The aim of this non-cohort stu...
Despite modern advances in the treatment of head and neck cancer, the survival rate fails to improve...